5AM Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Ensomaensoma.comMay 2023 · $50M
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Board seatKush M ParmarPaula Soteropoulos· per SEC Form D
Co-investorsAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta VenturesAlexandria+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.